Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases
- PMID: 12707137
- DOI: 10.1213/01.ANE.0000063923.87560.37
Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases
Comment in
-
There should be a threshold dose for the FDA black-box warning on droperidol.Anesth Analg. 2003 Nov;97(5):1543. doi: 10.1213/01.ANE.0000077672.77618.22. Anesth Analg. 2003. PMID: 14570685 No abstract available.
-
Reviewing case reports and the droperidol warning: FDA response.Anesth Analg. 2003 Nov;97(5):1542. doi: 10.1213/01.ANE.0000077671.77618.F9. Anesth Analg. 2003. PMID: 14570686 No abstract available.
-
Safety of patients reason for FDA black box warning on droperidol.Anesth Analg. 2004 Feb;98(2):552. doi: 10.1213/01.ANE.0000077705.55641.6B. Anesth Analg. 2004. PMID: 14742409 No abstract available.
References
-
- White PF. Droperidol: a cost-effective antiemetic for over thirty years. Anesth Analg 2002; 95: 789–90.
-
- White PF, Watcha MF. Postoperative nausea and vomiting: prophylaxis versus treatment [editorial]. Anesth Analg 1999; 89: 1337–9.
-
- Watcha MF. The cost-effective management of postoperative nausea and vomiting. Anesthesiology 2000; 92: 931–3.
-
- Gan TJ, White PF, Scuderi PE, et al. FDA “Black Box” warning regarding use of droperidol for postoperative nausea and vomiting: is it justified? Anesthesiology 2002; 97: 287.
-
- Bailey P, Norton R, Karan S. The FDA droperidol warning: is it justified? Anesthesiology 2002; 97: 288–9.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical